Ligand Pharmaceuticals Inc (LGND)

07:45 AM

What drives Ligand Pharmaceuticals Incorporated stock priceBreakout portfolio performance - Autocar Professional

07:45 AM

07:25 AM

Ligand Pharmaceuticals Incorporated Stock Analysis and ForecastHigh-margin investment plays - PrintWeekIndia

07:25 AM

Jul 24, 2025

Mark Your Calendar: Ligand Q2 2025 Earnings Report Coming August 7Key Details Inside - Stock Titan

Jul 24, 2025

Jul 23, 2025

What analysts say about Ligand Pharmaceuticals Incorporated stockExceptional trading performance - Autocar Professional

Jul 23, 2025

Jul 22, 2025

Is Ligand Pharmaceuticals Incorporated a good long term investmentHigh-velocity capital appreciation - jammulinksnews.com

Jul 22, 2025

Jul 18, 2025

Is Ligand Pharmaceuticals Incorporated stock a growth or value playFree Capital Allocation Plans - beatles.ru

Jul 18, 2025

Jul 17, 2025

Stifel reiterates Buy rating on Ligand Pharma stock at $143 price target - Investing.com Canada

Jul 17, 2025

Jul 17, 2025

Teacher Retirement System of Texas Has $534,000 Holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - Defense World

Jul 17, 2025

Jul 16, 2025

Ligand Pharmaceuticals stock hits 52-week high at 130.0 USD - Investing.com Australia

Jul 16, 2025

Jul 16, 2025

Ligand Pharmaceuticals stock hits 52-week high at 130.0 USD By Investing.com - Investing.com Nigeria

Jul 16, 2025

Jul 15, 2025

What makes Ligand Pharmaceuticals Incorporated stock price move sharplyHigh Yield Opportunities - Newser

Jul 15, 2025

Jul 15, 2025

How Ligand Pharmaceuticals Incorporated stock performs during market volatilityFree Real-Time Trading Opportunities - Newser

Jul 15, 2025

Jul 15, 2025

Why Ligand Pharmaceuticals Incorporated stock attracts strong analyst attentionFree Access to Community - Newser

Jul 15, 2025

Jul 15, 2025

Craig-Hallum Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Announces Target Price $140 - 富途牛牛

Jul 15, 2025

Jul 14, 2025

Principal Financial Group Inc. Acquires 3,284 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - Defense World

Jul 14, 2025

Jul 11, 2025

Insider Sell Alert: John Kozarich Sells Shares of Ligand Pharmac - GuruFocus

Jul 11, 2025

Jul 11, 2025

Ligand Pharmaceuticals director Kozarich sells $116k in stock By Investing.com - Investing.com South Africa

Jul 11, 2025

Jul 11, 2025

Ligand Pharmaceuticals director Kozarich sells $116k in stock - Investing.com Australia

Jul 11, 2025

Jul 11, 2025

Ligand Pharmaceuticals Director John Kozarich Sells 934 Shares at $125/Share. - AInvest

Jul 11, 2025

Jul 11, 2025

Amalgamated Bank Has $564,000 Position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - Defense World

Jul 11, 2025

Jul 11, 2025

Ligand earns $5 million milestone as partner launches molluscum treatment By Investing.com - Investing.com South Africa

Jul 11, 2025

Jul 10, 2025

Ligand Pharmaceuticals (LGND) Soars 2.11% on ZELSUVMI Launch, Milestone Payment - AInvest

Jul 10, 2025

Jul 10, 2025

Pelthos Therapeutics shares rise 1.27% in after-hours after commercial launch of ZELSUVMI™ and merger with Channel Therapeutics. - AInvest

Jul 10, 2025

Jul 10, 2025

Pelthos, Ligand Gain After Launch Of First Prescription-At-Home Treatment For Water Warts - Stocktwits

Jul 10, 2025

Jul 10, 2025

ZELSUVMI's FDA Approval: A Breakthrough for Pelthos and a Windfall for Ligand? - AInvest

Jul 10, 2025

Jul 10, 2025

ZELSUVMI Launch Positions Ligand Pharmaceuticals for Growth in a Booming Skin Care Market - AInvest

Jul 10, 2025

Jul 10, 2025

Ligand earns $5 million milestone as partner launches molluscum treatment - Investing.com

Jul 10, 2025

Jul 10, 2025

Ligand Partner Pelthos Therapeutics Launches ZELSUVMI - MarketScreener

Jul 10, 2025

Jul 10, 2025

Ligand Pharmaceuticals Partner Pelthos Launches Molluscum Contagiosum Treatment Zelsuvmi - MarketScreener

Jul 10, 2025

Jul 10, 2025

Ligand (LGND) Advances with Successful Launch of ZELSUVMI Gel | - GuruFocus

Jul 10, 2025

Jul 10, 2025

Ligand Pharmaceuticals Partner Pelthos Therapeutics Launches ZELSUVMI™ for Molluscum Contagiosum Treatment - Quiver Quantitative

Jul 10, 2025

Jul 10, 2025

Ligand Partner Pelthos Therapeutics Launches ZELSUVMI™ - GlobeNewswire

Jul 10, 2025

Jul 10, 2025

Breakthrough: First-Ever At-Home Treatment for Molluscum LaunchesLigand Secures $5M Milestone Payment - Stock Titan

Jul 10, 2025

Jul 09, 2025

GAMMA Investing LLC Has $62,000 Stock Position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - Defense World

Jul 09, 2025

Jul 05, 2025

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Receives Average Recommendation of “Buy” from Analysts - Defense World

Jul 05, 2025

Jul 03, 2025

Ligand’s LNHC concludes merger with CHRO - Yahoo Finance

Jul 03, 2025

Jul 02, 2025

Ligand Pharma Completes Merger Forming Pelthos Therapeutics - TipRanks

Jul 02, 2025

Jul 02, 2025

Ligand Announces Completion of Pelthos Therapeutics Merger with Channel Therapeutics - The Manila Times

Jul 02, 2025

Jul 02, 2025

Pelthos Therapeutics to Launch ZELSUVMI™ for Molluscum Contagiosum in July 2025 Following Merger with Ligand Pharmaceuticals - Quiver Quantitative

Jul 02, 2025

Jul 02, 2025

Ligand completes merger, Pelthos to launch molluscum treatment - Investing.com

Jul 02, 2025

Jul 02, 2025

Pelthos Therapeutics Completes Merger with Channel Therapeutics and Closes $50.1 Million Private Placement - GlobeNewswire

Jul 02, 2025

Jun 30, 2025

Ligand Pharmaceuticals Incorporated(NasdaqGM:LGND) added to Russell 2000 Growth-Defensive Index - MarketScreener

Jun 30, 2025

Jun 24, 2025

Ligand Pharmaceuticals: How a Biotech Royalty Model Drives Sustainable Growth - AInvest

Jun 24, 2025